DG
GSK icon

Davidson & Garrard’s GSK GSK Stock Holding History

Davidson & Garrard’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,027
Closed -$202K – 178
2014
Q2 		$202K Sell
3,027
-40
-1% -$2.71K 0.05% 171
2014
Q1 		$205K Sell
3,067
-80
-3% -$5.41K 0.05% 172
2013
Q4 		$210K Sell
3,147
-292
-8% -$18.9K 0.05% 179
2013
Q3 		$216K Buy
3,439
+40
+1% +$2.58K 0.06% 167
2013
Q2 		$212K Buy
+3,399
New +$216K 0.06% 160

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Davidson & Garrard's GSK Position: Q3 2014 in Review

Davidson & Garrard sold out of GSK (GSK) in Q3 2014, closing a stake of 3,027 shares — an estimated $202K sold.

Davidson & Garrard first reported a position in GSK in Q2 2013 and held it in 5 quarters. The position peaked at $216K in Q3 2013. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • Davidson & Garrard reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
  • Davidson & Garrard sold 3,027 GSK shares in Q3 2014, an estimated $202K.
  • Davidson & Garrard first reported a position in GSK in Q2 2013 and held it in 5 quarters.
  • Davidson & Garrard's GSK position peaked at $216K in Q3 2013.
  • 701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Davidson & Garrard's 13F filing for Q3 2014, filed 6 Nov 2014.